PMID: 2478806Jan 1, 1989Paper

The role of dopamine receptors in the treatment of congestive heart failure.

Journal of Cardiovascular Pharmacology
L I Goldberg

Abstract

Dopamine (DA) has been used for more than 25 years for treatment of congestive heart failure (CHF). Low infusion rates of DA (approximately 0.2-2 micrograms/kg/min) activate DA1 and DA2 dopamine receptors. Action on DA1 receptors results in vasodilation, primarily in the renal, mesenteric, and coronary vascular beds, and induces natriuresis. Action on DA2 receptors causes inhibition of norepinephrine release from sympathetic nerves. At medium infusion rates (approximately 2-5 micrograms/kg/min), beta 1-adrenoceptors are recruited and cardiac contractility increases. This infusion rate is usually used for the treatment of CHF. DA agonists with different receptor action than DA produce beneficial hemodynamic effects in patients with CHF: propylbutyl-DA (DA1 and DA2 receptors), bromocriptine (DA2 receptors), fenoldopam (DA1 receptors), and dopexamine (DA1 and DA2 receptors, and beta 2-adrenoceptors). Oral administration of three prodrugs (levodopa, ibopamine, and TA-8704) improve hemodynamics in patients with chronic CHF. Additional studies are required to determine whether drugs acting on DA receptors will have unique value in the long-term treatment of CHF.

Citations

Mar 1, 1995·Clinical Cardiology·M Metra, L Dei Cas
May 23, 1998·Journal of Clinical Pharmacology·J B Post, W H Frishman
Apr 1, 1994·British Journal of Clinical Pharmacology·N V OlsenP P Leyssac
May 17, 2011·Diabetes, Obesity & Metabolism·D S H Bell
Sep 1, 1996·Journal of Cardiac Failure·P LeszekJ Korewicki
Oct 26, 2011·The Journal of Physiology·Michael K SticklandM Sean McMurtry
Dec 11, 2007·Journal of the American College of Cardiology·Denise Hilfiker-KleinerHelmut Drexler
Jun 3, 2004·The Annals of Pharmacotherapy·Prashant KaushikRicha Kaushik
Nov 21, 2015·Journal of Applied Physiology·Jacqueline K LimbergMichael J Joyner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.